Main Session
Oct 01
SS 45 - GU 10: Biomarker Breakthroughs in Prostate Cancer

357 - Testosterone Recovery post Androgen Depletion Therapy in Intermediate Risk Prostate Cancer Patients. Does a Higher Dose of Radiotherapy Impact on Survival? Long-Term Data from a Phase III Trial

10:30am - 10:40am PT

Presenter(s)

Abdenour Nabid, MD Headshot
Abdenour Nabid, MD - CHUS, Sherbrooke, QC